Evidence map›Paper›PMID 40940992›Full record

ArticleCancers2025

Prognostic Significance and Emerging Predictive Potential of Interleukin-1β Expression in Oncogene-Driven NSCLC.

Mengni Guo, Won Jin Jeon, Bowon Joung, Derek Tai, Alexander Gavralidis, Andrew Elliott, Yasmine Baca, David de Semir, Stephen V Liu, Mark Reeves and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mengni GuoDivision of Hematology and Oncology, Loma Linda University, Loma Linda, CA 92354, USA.ORCID 0000-0003-2978-8607
Won Jin JeonDivision of Hematology and Oncology, Loma Linda University, Loma Linda, CA 92354, USA.ORCID 0000-0001-5212-5284
Bowon JoungDivision of Hematology and Oncology, Loma Linda University, Loma Linda, CA 92354, USA.ORCID 0009-0000-9797-4511
Derek TaiDepartment of Internal Medicine, Loma Linda University, Loma Linda, CA 92354, USA.ORCID 0000-0002-6461-5560
Alexander GavralidisDivision of Hematology and Oncology, Loma Linda University, Loma Linda, CA 92354, USA.
Andrew ElliottCaris Life Sciences Inc., Phoenix, AZ 85040, USA.ORCID 0000-0001-8494-8031
Yasmine BacaCaris Life Sciences Inc., Phoenix, AZ 85040, USA.
David de SemirCaris Life Sciences Inc., Phoenix, AZ 85040, USA.ORCID 0000-0001-8250-2183
Stephen V LiuLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA.
Mark ReevesDivision of Hematology and Oncology, Loma Linda University, Loma Linda, CA 92354, USA.
Saied MirshahidiLoma Linda University Cancer Center, Loma Linda University, Loma Linda, CA 92354, USA.ORCID 0000-0003-1747-8070
Hamid MirshahidiDivision of Hematology and Oncology, Loma Linda University, Loma Linda, CA 92354, USA.ORCID 0000-0002-7911-7118

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ALKEGFRinterleukin-1βKRASNSCLConcogenic mutationssurvival outcomestumor microenvironment

Identifiers

PMID40940992
PMCPMC12428403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.